Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Hodgkin Disease 1Breast Neoplasms 1

Interventions

Specimen Handling 271Magnetic Resonance Spectroscopy 222pembrolizumab 216Carboplatin 175Biopsy 166Cisplatin 155Nivolumab 150Cyclophosphamide 135Paclitaxel 120Radiotherapy 117Gemcitabine 111Bevacizumab 93durvalumab 85Dexamethasone 83Rituximab 76Oxaliplatin 71atezolizumab 70Doxorubicin 67Capecitabine 67Fluorouracil 66venetoclax 65Etoposide 64Docetaxel 64Radiosurgery 58Radiation 57Cytarabine 57Prednisone 56Pemetrexed 55Ipilimumab 55Lenalidomide 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Biopsy, Large-Core Needle × 90 days × Clear all
NCT03418038 2026-04-16

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Mayo Clinic

Phase 2 Recruiting
80 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡